Unitaid
In Sierra Leone, preventing tuberculosis requires more than access to medicines. Stigma, misinformation, distance and daily challenges continue to keep many people from seeking care or completing t...
HIV still affects millions of people worldwide, yet stigma, fear and shame continue to stop many from getting tested or starting treatment early. In this video, Christine Nakalembe, a community cha...
HIV still affects millions of people worldwide, yet stigma, fear and shame continue to stop many from getting tested or starting treatment early. In this video, Christine Nakalembe, a community cha...
Children living with HIV are especially vulnerable. Their immune systems are still developing, which means the disease can progress more quickly and increase the risk of advanced HIV disease. In th...
Children living with HIV are especially vulnerable. Their immune systems are still developing, which means the disease can progress more quickly and increase the risk of advanced HIV disease. In th...
HIV often shows few symptoms in its early stages, which means many people do not know their status until their immune system is already severely weakened. This stage, known as advanced HIV disease,...
HIV often shows few symptoms in its early stages, which means many people do not know their status until their immune system is already severely weakened. This stage, known as advanced HIV disease,...
Helen’s story shows the real impact of reaching people with advanced HIV disease in time. Too many individuals are still diagnosed late, putting them at high risk of life-threatening infections tha...
Helen’s story shows the real impact of reaching people with advanced HIV disease in time. Too many individuals are still diagnosed late, putting them at high risk of life-threatening infections tha...
On 1 October 2025, Robert Matiru, Unitaid’s Director of Programs, delivered remarks at the opening of a special Ministerial Technical Session of PAHO’s Directing Council on the 30+ Best Buys Diseas...
Unitaid is proud to support the Partnership for Vivax Elimination, which is helping countries bring innovative solutions to patients faster. In Peru, evidence from the PAVE-Peru study, led by Medic...
“Even the most promising innovation cannot reach its potential without being affordable,” said Carmen Pérez Casas, Senior strategy lead at Unitaid. “Lenacapavir is a revolutionary tool for HIV prev...
“By bringing the cost of long-acting injectable prevention on par with oral PrEP, countries now have a stronger economic case to scale up access widely,” said Vincent Bretin, Director of Results an...
“Incluso la innovación más prometedora no puede alcanzar su potencial si no es asequible,” dijo Carmen Pérez Casas, líder de estrategia en Unitaid. “Lenacapavir es una herramienta revolucionaria pa...
"With this model, we’ve shortened the timeline from innovation to impact, moving from over a decade of delay to less than two years between regulatory approvals in high-income countries and access ...
“When communities, civil society, and governments work together, access becomes real,” said Tenu Avafia, Deputy Executive Director of Unitaid. “With price parity now secured, we must ensure strong ...